Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow Quality Index

Latest as of March 2026: 2.00x

Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow Quality Index of 2.00x as of March 2026. Operating cash flow of ₩4.53 Billion exceeds net income of ₩2.27 Billion, indicating high earnings quality where cash backs reported profits. Explore Jin Yang Pharmaceutical Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

2.00x
Operating CF / Net Income

Operating Cash Flow

₩4.53 Billion
KRW

Net Income

₩2.27 Billion
KRW

Data as of

Mar 2026
Most recent filing

Jin Yang Pharmaceutical Co. Ltd Cash Flow Quality Index (2014–2025)

Historical Cash Flow Quality Index for Jin Yang Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Jin Yang Pharmaceutical Co. Ltd cash flow conversion.

Annual Cash Flow Quality Index for Jin Yang Pharmaceutical Co. Ltd (2014–2025)

Year-by-year earnings quality comparison for Jin Yang Pharmaceutical Co. Ltd.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2025 0.07x ₩1.46 Billion ₩22.29 Billion ▼ -84.7%
2024 0.43x ₩12.79 Billion ₩29.69 Billion ▼ -36.1%
2023 0.67x ₩8.53 Billion ₩12.66 Billion ▲ +11.4%
2022 0.61x ₩7.45 Billion ₩12.31 Billion ▲ +192.9%
2021 0.21x ₩1.97 Billion ₩9.54 Billion ▼ -87.8%
2020 1.70x ₩6.24 Billion ₩3.68 Billion ▼ -61.2%
2019 4.38x ₩7.21 Billion ₩1.65 Billion ▲ +285.9%
2018 1.13x ₩1.06 Billion ₩933.15 Million ▲ +247.7%
2014 -0.77x ₩-3.08 Billion ₩4.01 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.